drugset / Trial / NCT00976092

Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction

NCT00976092 ↗

Phase 4 Unknown 548 enrolled German Heart Center Munich
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized comparison of two different anticoagulation strategies: prasugrel plus bivalirudin versus clopidogrel plus heparin in patients with acute myocardial infarction undergoing emergency catheterization and coronary intervention.

Timeline

Start
2009-09
Primary completion
2014-02
Completion
2015-02

Outcome

Missed primary endpoint

paper relative risk, 1.09; one-sided 97.5% confidence interval (CI) 0-1.79, P = 0.680 PMID 24816809 ↗

paper we were unable to demonstrate significant differences in net clinical outcome between prasugrel plus bivalirudin and clopidogrel plus heparin. PMID 24816809 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Bivalirudin Peptide 1.75 mg/kg Intravenous
Comparator Clopidogrel Small molecule 600 mg —
Comparator Heparin Other / unclassified 70 iu/kg Intravenous
Comparator Heparin Other / unclassified 100 iu/kg Intravenous
Subject Prasugrel Small molecule 60 mg —

Indications